Brind.

Analyst Ratings and Target Price Raises Affect Diversified Healthcare Trust Stock

1 report, 1 independent Updated Tue 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

MarketBeat reports that Diversified Healthcare Trust (NASDAQ:DHC) holds an average rating of “Moderate Buy” from six research firms. The average 1-year price objective among these firms is $9.83. The company has seen various analyst actions, including Royal Bank of Canada raising its target price from $6.00 to $8.00 and assigning a “sector perform” rating in a June 18th note.

From dailypolitical.com

Why it matters

Some supportBrind's analysis of the reports

The consensus among research firms regarding DHC's stock carries implications for market sentiment. The ratings reflect institutional views on the company's valuation and future prospects.

From dailypolitical.com

Who's involved

  • MarketBeatAggregates and reports on the consensus ratings for DHC stock.
  • Royal Bank of CanadaRaised the target price on Diversified Healthcare Trust during June 2026.
  • NasdaqServes as the electronic stock exchange where DHC trades.

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped